Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nadolol + GVO for Gastric Variceal Bleeding
NCT00567216Phase 4Unknown
- Sponsor
- Taipei Veterans General Hospital
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nadolol in gastric varices (2 arms), sponsored by Taipei Veterans General Hospital. Primary endpoint: Rebleeding Rate at 3 years. Status: unknown.
02
Drugs
nadolol
03
Conditions
gastric varices
Beyond the preview
Go deeper on NCT00567216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00567216.